Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Abstract Text:

Wolfgang Kamin,Astrid Schwabe,Irene Krämer,Wolfgang Kamin,Astrid Schwabe,Irene ,

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Publishing Authors By Initials

W Kamin,A Schwabe,I Krämer,W Kamin,A Schwabe,I ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of chronic obstructive pulmo

VOLUME: 2

Page Numbers: 599-607

Journal Abbreviation:

ISSN: 1176-9106

DAY: 13

MONTH: 02

YEAR: 2007

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101273481

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.

AFFILIATION:

Country: New Zealand

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Chron Obstruct Pulmon Di

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions Related Publications

• Adrenal aldosterone biosynthesis is elevated in a model of chronic renal failure--role of local adrenal renin-angiotensin system.
• Allosteric control of oligonucleotide hybridization by metal-induced cyclization.
• Alpha-tocopherol influences the lipid membrane affinity of desipramine in a pH-dependent manner.
• Assessing Psychological Stress among Arab Migrant Women in the City of Cologne/Germany Using the Community Oriented Primary Care (COPC) Approach.
• Bi5O7Br and its structural relation to alpha-Bi5O7I.
• Changes and measurement of height and angle in the lumbosacral region.
• Contribution of smoking and air pollution exposure in urban areas to social differences in respiratory health.
• Dynamics and Cleavability at the {alpha}-Cleavage Site of APP(684-726) in Different Lipid Environments.
• Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
• Factors associated with lack of postnatal care among Palestinian women: a cross-sectional study of three clinics in the West Bank.
• Hook2 contributes to aggresome formation.
• JAK2-V617F and BCR-ABL-Double Jeopardy?
• No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation.
• Osmolality, temperature, and membrane lipid composition modulate the activity of betaine transporter BetP in Corynebacterium glutamicum.
• P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.
• Pharmacy and pharmacology of biosimilars.
• Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
• Predictors of overweight and obesity in five to seven-year-old children in Germany: results from cross-sectional studies.
• Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies.
• Smoking behaviour of patients before and after renal transplantation.
• Telmisartan, ramipril, or both in patients at high risk of vascular events.
• The biochemistry of drug metabolism--an introduction: part 3. Reactions of hydrolysis and their enzymes.
• The endoscopic treatment of carpal tunnel syndrome as an outpatient procedure.
• Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.
• [Characteristics of pharmacotherapy of epilepsy in the elderly]
• [Endovascular therapy of infrarenal aortic aneurysms: preinterventional imaging and follow-up.]
• [Epileptic seizures and epilepsy in the elderly]
• [Gabapentin (Neurontin): a new possibility in the add-on therapy of partial epilepsies]
• [Health statistics as a principle in health planning]
• [Neurobehavioral and systemic effects in lead-exposed rats after an exposure-free interval of four months duration (author's transl)]